Literature DB >> 21521346

Effects of a three-month combined exercise programme on fibroblast growth factor 21 and fetuin-A levels and arterial stiffness in obese women.

Sae Jeong Yang1, Ho Cheol Hong, Hae Yoon Choi, Hye Jin Yoo, Geum Ju Cho, Teak Geun Hwang, Sei Hyun Baik, Dong Seop Choi, Seon Mi Kim, Kyung Mook Choi.   

Abstract

OBJECTIVE: We examined the relationship between brachial-ankle pulse wave velocity (baPWV) reflecting arterial stiffness and the levels of novel hepatokines fibroblast growth factor 21 (FGF21) and fetuin-A. In addition, we evaluated the effect of a 3-month combined aerobic and resistance exercise programme on FGF21 and fetuin-A levels as well as arterial stiffness in obese women.
METHODS: Forty nondiabetic, obese women (body mass index = 27·6 ± 2·4 kg/m(2) ) were included in the study and were compared before and after a 3-month exercise programme, which was composed of 45 min of aerobic exercise at an intensity of 60-75% of the age-predicted maximum heart rate (300 kcal/session) and 20 min of resistance training (100 kcal/session) five times a week. All exercise sessions were supervised by a professional exercise physiologist.
RESULTS: At baseline, baPWV levels were correlated with age, body mass index (BMI), systolic blood pressure (SBP), high density lipoprotein cholesterol, fasting glucose and serum FGF21 levels. In a multiple stepwise regression analysis using baPWV as a dependent variable, baPWV levels were associated with age, BMI, SBP, FGF21 and fetuin-A levels (R(2) = 0·744). After the exercise programme, BMI, waist circumference, SBP, diastolic blood pressure and triglyceride levels were significantly decreased. Moreover, baPWV values were significantly improved (P < 0·001) along with modest decrease in FGF21 levels (P = 0·043). However, fetuin-A levels were not changed significantly (P = 0·202).
CONCLUSIONS: A 3-month combined exercise programme decreases the FGF21 levels as well as arterial stiffness in obese Korean women.
© 2011 Blackwell Publishing Ltd.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21521346     DOI: 10.1111/j.1365-2265.2011.04078.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  44 in total

Review 1.  Novel Mediators of Adipose Tissue and Muscle Crosstalk.

Authors:  Ira Indrakusuma; Henrike Sell; Jürgen Eckel
Journal:  Curr Obes Rep       Date:  2015-12

2.  Exercise-induced lowering of fetuin-A may increase hepatic insulin sensitivity.

Authors:  Steven K Malin; Juan Pablo del Rincon; Hazel Huang; John P Kirwan
Journal:  Med Sci Sports Exerc       Date:  2014-11       Impact factor: 5.411

Review 3.  Myokines in insulin resistance and type 2 diabetes.

Authors:  Kristin Eckardt; Sven W Görgens; Silja Raschke; Jürgen Eckel
Journal:  Diabetologia       Date:  2014-03-28       Impact factor: 10.122

4.  Fibroblast growth factor 21 and exercise-induced hepatic mitochondrial adaptations.

Authors:  Justin A Fletcher; Melissa A Linden; Ryan D Sheldon; Grace M Meers; E Matthew Morris; Anthony Butterfield; James W Perfield; John P Thyfault; R Scott Rector
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-03-24       Impact factor: 4.052

Review 5.  The Potential Role of Fibroblast Growth Factor 21 in Lipid Metabolism and Hypertension.

Authors:  Zhe Huang; Aimin Xu; Bernard M Y Cheung
Journal:  Curr Hypertens Rep       Date:  2017-04       Impact factor: 5.369

6.  Associations between serum hepcidin level, FGF-21 level and oxidative stress with arterial stiffness in CAPD patients.

Authors:  Sena Memnune Ulu; Seref Yuksel; Atila Altuntaş; Emre Kacar; Ahmet Ahsen; Abdullah Altug; Sefa Celik; M Tugrul Sezer
Journal:  Int Urol Nephrol       Date:  2014-06-08       Impact factor: 2.370

Review 7.  The roles of FGF21 in atherosclerosis pathogenesis.

Authors:  Farzane Shanebandpour Tabari; Ansar Karimian; Hadi Parsian; Vahid Rameshknia; Ata Mahmoodpour; Maryam Majidinia; Mahmood Maniati; Bahman Yousefi
Journal:  Rev Endocr Metab Disord       Date:  2019-03       Impact factor: 6.514

Review 8.  Fetuin-A: a novel link between obesity and related complications.

Authors:  J F Trepanowski; J Mey; K A Varady
Journal:  Int J Obes (Lond)       Date:  2014-12-03       Impact factor: 5.095

9.  Effects of insulin and exercise training on FGF21, its receptors and target genes in obesity and type 2 diabetes.

Authors:  Rikke Kruse; Sara G Vienberg; Birgitte F Vind; Birgitte Andersen; Kurt Højlund
Journal:  Diabetologia       Date:  2017-07-18       Impact factor: 10.122

Review 10.  Fibroblast growth factors in cardiovascular disease: The emerging role of FGF21.

Authors:  Eleni M Domouzoglou; Katerina K Naka; Antonios P Vlahos; Michail I Papafaklis; Lampros K Michalis; Agathoklis Tsatsoulis; Eleftheria Maratos-Flier
Journal:  Am J Physiol Heart Circ Physiol       Date:  2015-07-31       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.